IMPACT OF VISUAL IMPAIRMENT ON USE OF CAREGIVING BY INDIVIDUALS WITH AGE-RELATED MACULAR DEGENERATION-Reference-Cited by-同舟云学术

IMPACT OF VISUAL IMPAIRMENT ON USE OF CAREGIVING BY INDIVIDUALS WITH AGE-RELATED MACULAR DEGENERATION

Published:2006-11 Issue:9 Volume:26 Page:1056-1062
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

SCHMIER JORDANA K.,HALPERN MICHAEL T.,COVERT DAVID,DELGADO JUDITH,SHARMA SANJAY

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference27 articles.

1. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.;Bressler;Arch Ophthalmol,2003

2. Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study report number 3.;Ophthalmology,2000

3. Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study.;Augood;Ophthalmic Epidemiol,2004

4. Sun exposure and age-related macular degeneration. An Australian case-control study.;Darzins;Ophthalmology,1997

5. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.;Klein;Ophthalmology,1997

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Portable Virtual Reality to Assess Mobility of Blind and Low-Vision Individuals With the Audomni Sensory Supplementation Feedback;IEEE Access;2024

2. The case for investment in eye health: systematic review and economic modelling analysis;Bulletin of the World Health Organization;2023-12-01

3. The Impact of Neighborhood Factors on Physical Activity in Older Adults With Visual Impairment;American Journal of Ophthalmology;2023-06

4. Time and Distance Cost of Longer Acting Anti-VEGF Therapies for Macular Degeneration: Contributions to Drug Cost Comparisons;Clinical Ophthalmology;2022-12

5. Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland;BMC Health Services Research;2022-06-28